173 related articles for article (PubMed ID: 7884859)
1. Mutations within a putative cysteine loop of the transmembrane protein of an attenuated immunodeficiency-inducing feline leukemia virus variant inhibit envelope protein processing.
Burns CC; Poss ML; Thomas E; Overbaugh J
J Virol; 1995 Apr; 69(4):2126-32. PubMed ID: 7884859
[TBL] [Abstract][Full Text] [Related]
2. Delayed cytopathicity of a feline leukemia virus variant is due to four mutations in the transmembrane protein gene.
Thomas E; Overbaugh J
J Virol; 1993 Oct; 67(10):5724-32. PubMed ID: 8396654
[TBL] [Abstract][Full Text] [Related]
3. Feline leukemia virus envelope sequences that affect T-cell tropism and syncytium formation are not part of known receptor-binding domains.
Gwynn SR; Hankenson FC; Lauring AS; Rohn JL; Overbaugh J
J Virol; 2000 Jul; 74(13):5754-61. PubMed ID: 10846053
[TBL] [Abstract][Full Text] [Related]
4. Posttranslational modifications distinguish the envelope glycoprotein of the immunodeficiency disease-inducing feline leukemia virus retrovirus.
Poss ML; Mullins JI; Hoover EA
J Virol; 1989 Jan; 63(1):189-95. PubMed ID: 2535725
[TBL] [Abstract][Full Text] [Related]
5. In vivo evolution of a novel, syncytium-inducing and cytopathic feline leukemia virus variant.
Rohn JL; Moser MS; Gwynn SR; Baldwin DN; Overbaugh J
J Virol; 1998 Apr; 72(4):2686-96. PubMed ID: 9525586
[TBL] [Abstract][Full Text] [Related]
6. Characterization and significance of delayed processing of the feline leukemia virus FeLV-FAIDS envelope glycoprotein.
Poss ML; Quackenbush SL; Mullins JI; Hoover EA
J Virol; 1990 Sep; 64(9):4338-45. PubMed ID: 2166820
[TBL] [Abstract][Full Text] [Related]
7. Fusion-defective gibbon ape leukemia virus vectors can be rescued by homologous but not heterologous soluble envelope proteins.
Farrell KB; Ting YT; Eiden MV
J Virol; 2002 May; 76(9):4267-74. PubMed ID: 11932392
[TBL] [Abstract][Full Text] [Related]
8. Ancestral Mutations Acquired in Refrex-1, a Restriction Factor against Feline Retroviruses, during its Cooption and Domestication.
Ito J; Baba T; Kawasaki J; Nishigaki K
J Virol; 2016 Feb; 90(3):1470-85. PubMed ID: 26581999
[TBL] [Abstract][Full Text] [Related]
9. Mutational analysis of N-linked glycosylation sites of Friend murine leukemia virus envelope protein.
Kayman SC; Kopelman R; Projan S; Kinney DM; Pinter A
J Virol; 1991 Oct; 65(10):5323-32. PubMed ID: 1895386
[TBL] [Abstract][Full Text] [Related]
10. Distinct superinfection interference properties yet similar receptor utilization by cytopathic and noncytopathic feline leukemia viruses.
Reinhart TA; Ghosh AK; Hoover EA; Mullins JI
J Virol; 1993 Sep; 67(9):5153-62. PubMed ID: 8394443
[TBL] [Abstract][Full Text] [Related]
11. Conserved cysteine residues in the human immunodeficiency virus type 1 transmembrane envelope protein are essential for precursor envelope cleavage.
Dedera D; Gu RL; Ratner L
J Virol; 1992 Feb; 66(2):1207-9. PubMed ID: 1731099
[TBL] [Abstract][Full Text] [Related]
12. Structure and pathogenicity of individual variants within an immunodeficiency disease-inducing isolate of FeLV.
Overbaugh J; Hoover EA; Mullins JI; Burns DP; Rudensey L; Quackenbush SL; Stallard V; Donahue PR
Virology; 1992 Jun; 188(2):558-69. PubMed ID: 1316674
[TBL] [Abstract][Full Text] [Related]
13. A single point mutation in the envelope gene is responsible for replication and XC fusion deficiency of the endogenous ecotropic C3H/He murine leukemia virus and for its repair in culture.
Sithanandam G; Rapp UR
J Virol; 1988 Mar; 62(3):932-43. PubMed ID: 2828688
[TBL] [Abstract][Full Text] [Related]
14. Abnormal processing of a recombinant feline leukemia virus envelope polyprotein and its interference with subgroup C virus infection.
Bechtel MK; Stallcup MR; Bedgood RM; Corey JL; Pandey R; Roy-Burman P
Virology; 1994 Jul; 202(1):329-38. PubMed ID: 8009844
[TBL] [Abstract][Full Text] [Related]
15. Identification of envelope determinants of feline leukemia virus subgroup B that permit infection and gene transfer to cells expressing human Pit1 or Pit2.
Sugai J; Eiden M; Anderson MM; Van Hoeven N; Meiering CD; Overbaugh J
J Virol; 2001 Aug; 75(15):6841-9. PubMed ID: 11435563
[TBL] [Abstract][Full Text] [Related]
16. Recombinant feline herpesviruses expressing feline leukemia virus envelope and gag proteins.
Cole GE; Stacy-Phipps S; Nunberg JH
J Virol; 1990 Oct; 64(10):4930-8. PubMed ID: 2168977
[TBL] [Abstract][Full Text] [Related]
17. A single amino acid substitution in the transmembrane envelope glycoprotein of feline immunodeficiency virus alters cellular tropism.
Vahlenkamp TW; Verschoor EJ; Schuurman NN; van Vliet AL; Horzinek MC; Egberink HF; de Ronde A
J Virol; 1997 Sep; 71(9):7132-5. PubMed ID: 9261450
[TBL] [Abstract][Full Text] [Related]
18. Evolution of feline leukemia virus variant genomes with insertions, deletions, and defective envelope genes in infected cats with tumors.
Rohn JL; Linenberger ML; Hoover EA; Overbaugh J
J Virol; 1994 Apr; 68(4):2458-67. PubMed ID: 8139030
[TBL] [Abstract][Full Text] [Related]
19. Strong sequence conservation among horizontally transmissible, minimally pathogenic feline leukemia viruses.
Donahue PR; Hoover EA; Beltz GA; Riedel N; Hirsch VM; Overbaugh J; Mullins JI
J Virol; 1988 Mar; 62(3):722-31. PubMed ID: 2828667
[TBL] [Abstract][Full Text] [Related]
20. A single amino acid change in the cytoplasmic domain of the simian immunodeficiency virus transmembrane molecule increases envelope glycoprotein expression on infected cells.
LaBranche CC; Sauter MM; Haggarty BS; Vance PJ; Romano J; Hart TK; Bugelski PJ; Marsh M; Hoxie JA
J Virol; 1995 Sep; 69(9):5217-27. PubMed ID: 7636963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
